Richard Graydon
Technik-/Wissenschafts-/F&E-Leiter bei ATOSSA THERAPEUTICS, INC.
Aktive Positionen von Richard Graydon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 25.10.2022 | - |
Karriereverlauf von Richard Graydon
Ehemalige bekannte Positionen von Richard Graydon
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Richard Graydon
| Stanford University | Doctorate Degree |
| Cornell University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Börse
- Insiders
- Richard Graydon
- Erfahrung